The current case report presents a patient who underwent the serotonin syndrome after the administration of paroxetine and bupropion.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Serotonin syndrome is an important clinical condition that can occur after excessive central serotonergic activity, generally secondary to the use of combinations of antidepressants.
📊
Key Findings & Data:Selective serotonin reuptake inhibitors and bupropion are frequently used in the treatment of major depression in clinical practice.
💡
Conclusion & Impact:The current case report presents a patient who underwent the serotonin syndrome after the administration of paroxetine and bupropion.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Serotonin syndrome is an important clinical condition that can occur after excessive central serotonergic activity, generally secondary to the use of combinations of antidepressants. Selective serotonin reuptake inhibitors and bupropion are frequently used in the treatment of major depression in clinical practice. Few cases of serotonin syndrome due to the use of serotonergic antidepressants and bupropion have been reported in the literature. The current case report presents a patient who underwent the serotonin syndrome after the administration of paroxetine and bupropion.
🔖
Cite This Article
KIRKAŞ, A., UGUZ, F. (2020). Serotonin Syndrome in a Patient Using Paroxetine and Bupropion. Psychiatry and behavioral sciences (Online), Cilt: 10 - Sayı: 3, 155–157. https://ajindex.com/articles/302795
40 [2] Ables AZ, Nagubilli R. Prevention, diagnosis, and management of serotonin syndrome. Am Fam Physician 2010
Lane R, Baldwin D. Selective serotonin reuptake inhibitorinduced serotonin syndrome: review. J Clin Psychopharmacol 1997
Dvir Y, Smallwood P. Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry 2008
Dhillon S, Yang LP, Curran MP. Bupropion: A review of its use in the management of major depressive disorder. Drugs 2008
First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington D.C: American Psychiatric Press
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960
Munhoz RP. Serotonin syndrome induced by a combination of bupropion and SSRIs. Clin Neuropharmacol 2004
Thorpe EL, Pizon AF, Lynch MJ, Boyer J. Bupropion induced serotonin syndrome: a case report. J Med Toxicol 2010
Falls BA, Gurrera RJ. Serotonin syndrome in a patient on tramadol, bupropion, trazodone, and oxycodone. Psychosomatics 2014
Murray B, Carpenter J, Dunkley C, Moran TP, Kiernan EA, Rianprakaisang T, et al. Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity. J Med Toxicol 2020
39(6):628-633. [14] Sanchez C, Reines EH, Montgomery SA. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? Int Clin Psychopharmacol 2014
Costa R, Oliveira NG, Dinis-Oliveira RJ. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metab Rev. 2019
Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned- Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004
El Mansari M, Ghanbari R, Janssen S, Blier P. Sustained administration of bupropion alters the neur